Medpace (MEDP)
(Delayed Data from NSDQ)
$390.91 USD
+4.59 (1.19%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $390.50 -0.41 (-0.10%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Brokerage Reports
Medpace Holdings, Inc. [MEDP]
Reports for Purchase
Showing records 1 - 20 ( 124 total )
Company: Medpace Holdings, Inc.
Industry: Medical Services
Optimized Entry and Exit Levels for MEDP 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Life Science Tools & Services - Alert: MEDP Results and VC Funding Show CRO Debate Continuing and BioProcess Growth Visible
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Early Stage Funding Concerns Signaled Again
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Life Science, Bioproduction, CROs: Positive Data Points for 2023
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Transferring Coverage of 5 Companies, Suspending Coverage of 16 Companies, Terminating Coverage of 1 Company
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Growth Accelerating in 2021 and 2022 (Initial 3Q21 Takeaways)
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
In-Line 2Q21 Results Despite Biotech Concerns (Pre Conference Call)
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D